Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iatrogenic hepatic injury.

E Rubin

    Human Pathology
    |July 1, 1980
    PubMed
    Summary

    Drug-induced liver injury (DILI) is a growing concern, mimicking various liver conditions. Physicians must meticulously review patient medication history to diagnose DILI effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Machine-learning-based risk assessment tool to rule out empirical use of ESBL-targeted therapy in endemic areas.

    The Journal of hospital infection·2024
    Same author

    Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Comment.

    Statistics in biopharmaceutical research·2018
    Same author

    Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung.

    Oncogenesis·2016
    Same author

    Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

    Blood cancer journal·2014

    Area of Science:

    • Hepatology
    • Clinical Pharmacology
    • Toxicology

    Background:

    • Drug-induced liver injury (DILI) is a significant and increasingly prevalent clinical issue.
    • DILI can present with a wide spectrum of liver pathologies, resembling numerous known liver diseases.
    • Accurate patient drug history is crucial for identifying potential causative agents.

    Purpose of the Study:

    • To highlight the increasing incidence and diverse presentations of drug-induced liver injury.
    • To emphasize the importance of a thorough medication history in diagnosing liver disease.
    • To underscore the diagnostic challenge posed by DILI, which can mimic various hepatic conditions.

    Main Methods:

    • Review of clinical presentations of drug-induced liver injury.
    • Analysis of how DILI can manifest as diverse liver pathologies.
    • Emphasis on the diagnostic role of patient drug history.

    Main Results:

    • Drug-induced liver injury is common and rising.
    • DILI can present as cholestasis, steatosis, granulomas, hepatitis, cirrhosis, vascular disorders, and tumors.
    • A detailed drug history is essential for diagnosis.

    Conclusions:

    • Physicians must consider drug-induced liver injury in all patients with liver disease.
    • Thorough patient drug histories are imperative for accurate diagnosis and management of liver conditions.
    • The broad differential diagnosis of DILI necessitates careful evaluation of therapeutic drug exposure.

    Related Experiment Videos